Identification of fda-approved drugs against sars-cov-2 rna-dependent rna polymerase (rdrp) through computational virtual screening

HIGHLIGHTS

• who: Dhananjay Jade from the School of Biomedical Sciences, University of Leeds, Leeds, UK have published the research work: Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening, in the Journal: (JOURNAL) of 11/03/2020
• what: The aim of this study was to conduct an initial virtual screen of FDA-approved compounds in the DrugBank database, using 2D similarity screening to identify molecules with similar characteristics to remdesivir and molnupiravir.
• how: For this clustering method the authors used the 166-bit Open Babel . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.